Ascendis Pharma Investigational Site

Madrid 28050

1 studies enrolling now · 4 studies all time

What they study most

2L+ Cervical Cancer, Achondroplasia, Advanced Solid Tumor, Endocrine System Diseases, Growth Hormone Deficiency, Hormone Deficiency, Idiopathic Short Stature, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoadjuvant Melanoma, Neoadjuvant Non-Small Cell Lung Cancer, Platinum-resistant Ovarian Cancer

Studies at this site

• Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders — Recruiting now
• A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency — Completed
• A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling
• A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia — Completed